Top Tweets for #ALSYMPCA
Radium-223 in 2024 and Beyond: Resurrected and Disrupting the First-Line #mCRPC Treatment Landscape.
@RKSayyid @USC and @zklaassen_md @GACancerCenter review the pivotal #ALSYMPCA trial that led to initial FDA approval of radium-223, explore several hypotheses as to why radium-223 utilization has decreased in recent years, highlight the recent #PEACE3 trial findings, and emphasize implications and patient selection for utilizing radium-223 + enzalutamide in first-line mCRPC. #ReadNow > https://t.co/y33ojSEeje
Radium-223 in 2024 and Beyond: Resurrected and Disrupting the First-Line #mCRPC Treatment Landscape.
@RKSayyid @USC and @zklaassen_md @GACancerCenter review the pivotal #ALSYMPCA trial that led to initial FDA approval of radium-223, explore several hypotheses as to why radium-223 utilization has decreased in recent years, highlight the recent #PEACE3 trial findings, and emphasize implications and patient selection for utilizing radium-223 + enzalutamide in first-line mCRPC. #ReadNow > https://t.co/y33ojSEeje
Radium-223 in 2024 and Beyond: Resurrected and Disrupting the First-Line #mCRPC Treatment Landscape.
@RKSayyid @USC and @zklaassen_md @GACancerCenter review the pivotal #ALSYMPCA trial that led to initial FDA approval of radium-223, explore several hypotheses as to why radium-223 utilization has decreased in recent years, highlight the recent #PEACE3 trial findings, and emphasize implications and patient selection for utilizing radium-223 + enzalutamide in first-line mCRPC. #ReadNow > https://t.co/y33ojSEeje
Sequencing of radiopharmaceuticals in metastatic castration-resistant #ProstateCancer. @PBarataMD @caseccc joins @CaPsurvivorship @DanaFarber to review data from #ALSYMPCA, #VISION, #REASSURE, #WARMTH, and the #RALU Study. #WatchNow > https://t.co/1MWSBMUda4
Sequencing of radiopharmaceuticals in metastatic castration-resistant #ProstateCancer. @PBarataMD @caseccc joins @CaPsurvivorship @DanaFarber to review data from #ALSYMPCA, #VISION, #REASSURE, #WARMTH, and the #RALU Study. #WatchNow > https://t.co/1MWSBMUKZC
Sequencing of radiopharmaceuticals in metastatic castration-resistant #ProstateCancer. @PBarataMD @caseccc joins @CaPsurvivorship @DanaFarber to review data from #ALSYMPCA, #VISION, #REASSURE, #WARMTH, and the #RALU Study. #WatchNow > https://t.co/1MWSBMUda4
Sequencing of radiopharmaceuticals in metastatic castration-resistant #ProstateCancer. @PBarataMD @caseccc joins @CaPsurvivorship @DanaFarber to review data from #ALSYMPCA, #VISION, #REASSURE, #WARMTH, and the #RALU Study. #WatchNow > https://t.co/1MWSBMUda4
Sequencing of radiopharmaceuticals in metastatic castration-resistant #ProstateCancer. @PBarataMD @caseccc joins @CaPsurvivorship @DanaFarber to review data from #ALSYMPCA, #VISION, #REASSURE, #WARMTH, and the #RALU Study. #WatchNow > https://t.co/1MWSBMUda4
Flare reaction could occur after Ra-223 therapy, 16% based on the report. The 2+2 rule is used to confirmed disease progression after the therapy. #xofigo #ra223 #prostatecancer #prostate #alphatherapy #alsympca #nuclearmedicine #nm
Nuclear medicine centers should strive to maintain the recommended regimen of Ra-223 dichloride (6 cycles) to optimize survival outcome. #ra223 #xofigo #prostatecancer #prostate #alsympca #nejm #alphtherapy #nuclearmedicine #eanm #snmmi
The prognostic value of the baseline neutrophil-to-lymphocyte ratio in patients with #mCRPC receiving #Radium223: a post-hoc analysis of the #ALSYMPCA phase 3 trial. Presented by Alexander Meisel @Unispital_USZ. Written coverage by @zklaassen_md > https://t.co/Y1Rqg8GHzV #ESMO20
#WatchNow Radium-223 in clinical practice. @PhillipKooMD @BannerHealth and Neal Shore, MD, FACS @AtlanticUrology dive into the #ALSYMPCA trial and discuss maintaining bone health for patients with mCRPC https://t.co/ODoKvrSZn9
@DrewMoghanaki @PeteRossiMD Not at all! Lessons learned from this trial help us understand what should and should not be combined with 223-Ra. I look at the #Alsympca trial as the START of an era. 223-Ra now being explored in other cancers. Other #Radiopharmaceuticals being tested too.
Article on #CRPC Time to #SSE with #Ra-223 in Patients with CRPC and Bone #Metastases, #ALSYMPCA trial: -http://t.co/vv55tVPWJu
Last Seen Hashtags on Sotwe
hoejabi
Seen from Turkey
momson(*)
Seen from Philippines
lowlvl
Seen from Australia
monkeyapp
Seen from United States
cos
Seen from United States
xoog
Seen from United States
บราซิลเลี่ยน
Seen from Thailand
fuckmachine
Seen from United States
thundr
Seen from Switzerland
Momson #nolimit
Seen from Singapore
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.3M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
113M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.5M followers
KATY PERRY
@katyperry
89.1M followers
Taylor Swift
@taylorswift13
83M followers
Lady Gaga
@ladygaga
74.5M followers
Virat Kohli
@imvkohli
72M followers
Kim Kardashian
@kimkardashian
70.5M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
65M followers
Bill Gates
@billgates
64.7M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62.2M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers